Class IDrug
Thyroid Tablets recall
Summary
VITRUVIAS THERAPEUTICS INC is recalling Thyroid Tablets (drug). According to the FDA report, the reason is: Superpotent Drug. The FDA rated this a Class I: most serious: there is a reasonable chance the product could cause serious health problems or death. Recall status: Ongoing.
Understanding this recall
What happened
Vitruvias Therapeutics is recalling Thyroid Tablets USP (1/2 grain, 30 mg) because testing found them superpotent, meaning stronger than labeled.
Why it matters
A drug that is stronger (superpotent) or weaker (subpotent) than its label says can lead to overdose effects or to the condition not being treated properly. With medicines like thyroid hormone, where dosing is carefully adjusted, even small changes in strength can matter. Too much thyroid hormone can cause symptoms such as a rapid or irregular heartbeat, nervousness or trouble sleeping.
Who should pay attention
Patients prescribed this thyroid medication, and their pharmacists.
Distribution in the FDA report: US Nationwide.
How to check your product
Check the lot number and expiration date on the bottle or pharmacy label. Don't stop taking thyroid medication without talking to your prescriber or pharmacist.
Codes listed by the FDA: Lot # 504950, Exp Date: 09/30/2026.
Based only on the FDA enforcement record plus general public-health background on this type of hazard. Not medical advice; if you have symptoms or concerns, contact a doctor or pharmacist.
Details from the FDA report
- Product
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Reason
- Superpotent Drug
- Lot / code info
- Lot # 504950, Exp Date: 09/30/2026.
- Quantity
- 1955 bottles
- Distribution
- US Nationwide.
- Recalling company
- VITRUVIAS THERAPEUTICS INC, Auburn, AL United States
- Recall started
- August 21, 2026
- FDA report date
- September 23, 2026
- Classification
- Class I: Most serious: there is a reasonable chance the product could cause serious health problems or death.
- Voluntary / mandated
- Voluntary: Firm initiated
- Status
- Ongoing
- Recall number
- D-0866-2026
What to do
- Check whether you have this product, and compare the lot numbers, codes, or dates on your package with the codes listed above.
- If it matches, stop using it and keep it away from children and pets.
- Contact the recalling company (VITRUVIAS THERAPEUTICS INC) or the store where you bought it about returns or refunds.
- Do not stop a prescribed medication without first talking to your pharmacist or doctor; they can help find a safe replacement.
- If you think the product made you or someone else sick, contact a doctor or pharmacist. In an emergency call 911.
- You can report problems to the FDA via MedWatch.